Brandon Hull is an accomplished executive with extensive experience in technology, healthcare, and investment sectors. Currently serving as Chairman of Asylon Robotics since August 2015, Brandon leads a company specializing in automated security technology. In addition, Brandon holds the position of Executive Chairman at Silvas LLC, focusing on early-stage technology investments, and is a member of the Executive Advisory Council at New Mountain Capital. As an investor in Freenome, Brandon supports innovations in genetic material analysis for healthcare. With a history of directorship roles at Signify Health and Equian, and a founding role at the Digital Health Innovation Summit, Brandon has demonstrated leadership throughout their career, including over 20 years at athenahealth. Educationally, Brandon earned an MBA in Health Care Economics/Finance from The Wharton School and a BA in Literature & Philosophy from Wheaton College.